Baucus Comparative Effectiveness Bill Flirts With Cost Effectiveness Issue
Executive Summary
Legislation aimed at the development of a private, nonprofit corporation to drive comparative effectiveness research tentatively ventures into the realm of comparing the cost effectiveness of medical treatments
You may also be interested in...
Baucus to Proceed With Public/Private Comparative Effectiveness Vision
Even with the inclusion of comparative effectiveness research funding in the American Recovery and Reinvestment Act, Senate Finance Committee Chairman Max Baucus is showing no signs of abandoning plans to include comparative effectiveness in the upcoming health care reform debate
Baucus to Proceed With Public/Private Comparative Effectiveness Vision
Even with the inclusion of comparative effectiveness research funding in the American Recovery and Reinvestment Act, Senate Finance Committee Chairman Max Baucus is showing no signs of abandoning plans to include comparative effectiveness in the upcoming health care reform debate
PhRMA, BIO Alliance Promotes Industry Agenda On Comparative Effectiveness
The Pharmaceutical Research and Manufacturers of America, the Biotechnology Industry Organization and the Advanced Medical Technology Association have formed a coalition to promote an industry agenda on comparative clinical effectiveness